Letter | Published:

Effect of morphine on a depolarising dopamine response

Naturevolume 257pages238240 (1975) | Download Citation

Subjects

Abstract

THE structural complexity of nervous tissues and the presence of non-neuronal elements have hindered investigations into the actions of morphine at the cellular level in the vertebrate central nervous system, and contribute to the difficulty of determining whether morphine acts pre- or postsynaptically. Although presynaptic effects of morphine are documented, to our knowledge there has been no demonstration of an effect of morphine on postsynaptic neurotransmitter receptors using intracellular recording techniques.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Hamprecht, B., in Biochemistry of Sensory Functions (edit. by Jarnicke, L.), 391–423 (Springer, New York, 1974).

  2. 2

    Hamprecht, B., Traber, J., and Lamprecht, F., FEBS Lett., 42, 221–226 (1974).

  3. 3

    Hamprecht, B., and Amano, T., Analyt. Biochem., 57, 162 (1974).

  4. 4

    Daniels, M., and Hamprecht, B., J. Cell Biol., 63, 691–699 (1974).

  5. 5

    Ciofalo, F., Life Sci., 11, 573–580 (1972).

  6. 6

    Carmichael, F., and Israel, Y., J. Pharmac. exp. Ther., 186, 253–260 (1973).

  7. 7

    Hitzemann, R., and Loh, H., Eur. J. Pharmac., 21, 121–129 (1973).

  8. 8

    Celsen, B., and Kuschinsky, K., Naunyn-Schmiedeberg's Arch. Pharmac., 284, 159–165 (1974).

  9. 9

    Johnson, J., Ratner, M., Gold, G., and Clouet, D., Res. Commun. Chem. Path. Pharmac., 9, 41–53 (1974).

  10. 10

    Sugrue, M., Br. J. Pharmac., 52, 159–165 (1974).

  11. 11

    Puri, S., Reddy, C., and Lal, H., Res. Commun. Chem. Path. Pharmac., 5, 389–401 (1973).

  12. 12

    Clouet, D., and Ratner, M., Science, 168, 854–856 (1970).

  13. 13

    Smith, C., Villarreal, J., Badnarczyk, J., and Sheldon, M., Science, 170, 1106–1108 (1970).

  14. 14

    Hitzemann, R., Loh, H., Ho, A., and Way, E., Proc. West Pharmac. Soc., 14, 91 (1971).

  15. 15

    Cicero, T., Meyer, E., and Smithloff, B., J. Pharmac. exp. Ther., 189, 72–82 (1974).

  16. 16

    Cicero, T., Wilcox, C., and Meyer, E., Biochem. Pharmac., 23, 2349–2352 (1974).

  17. 17

    Fuxe, K., and Ungerstedt, U., in Amphetamines and Related Compounds (edit. by Costa, E. and Garattini, S.), 257–288 (Raven, New York, 1970).

  18. 18

    Bradley, P., and Dray, A., Br. J. Pharmac., 50, 47–55 (1974).

  19. 19

    Pert, C., and Snyder, S., Science, 179, 1011–1014 (1973).

  20. 20

    Klee, W., and Nirenberg, M., Proc. natn. Acad. Sci. U.S.A., 71, 3474–3477 (1974).

  21. 21

    Pert, C., and Snyder, S., Proc. natn. Acad. Sci. U.S.A., 70, 2243–2247 (1973).

  22. 22

    Myers, P. R., and Livengood, D. R., Nature, 255, 235 (1975).

Download references

Author information

Affiliations

  1. Department of Neurobiology, Armed Forces Radiobiology Research Institute, Defense Nuclear Agency, Bethesda, Maryland, 20014

    • PAUL R. MYERS
    • , DAVID R. LIVENGOOD
    •  & WILLIAM SHAIN

Authors

  1. Search for PAUL R. MYERS in:

  2. Search for DAVID R. LIVENGOOD in:

  3. Search for WILLIAM SHAIN in:

About this article

Publication history

Received

Accepted

Issue Date

DOI

https://doi.org/10.1038/257238a0

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.